Pneumococcal vaccination status in critically ill patients: A cross-sectional study [PDF]
Critically ill adults are often older and have multiple chronic conditions, but data on prior pneumococcal vaccination in this population are limited.
Tatsuya Watanabe +8 more
doaj +2 more sources
Determinants of Pneumococcal Vaccination Decision‐Making Among High‑Risk Adults: A Qualitative Study Guided by the Theoretical Domains Framework [PDF]
Background and Aims Pneumococcal disease (PD) poses a substantial burden among older adults and individuals with chronic conditions, yet pneumococcal vaccination uptake remains suboptimal in Hong Kong.
Claire Chenwen Zhong +5 more
doaj +2 more sources
Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany [PDF]
The epidemiological impact of lowering the vaccination age of German adults from 60 to 50 y was evaluated. An age- and serotype-specific dynamic transmission model was used to evaluate the impact of vaccination with either the 23-valent pneumococcal ...
Oluwaseun Sharomi +9 more
doaj +2 more sources
Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso
While suboptimal pneumococcal vaccination rates have been reported in immunosuppressed patients with rheumatic diseases, data for patients with psoriasis (PsO) or atopic dermatitis (AD) are scarce.
Phoebe Wellmann +8 more
doaj +2 more sources
Expert Consensus on Influenza Vaccine and Pneumococcal Vaccination in Elderly People With Chronic Respiratory Diseases (2024). [PDF]
Chronic respiratory diseases pose a serious threat to the health of the population due to their high incidence, high disability rate, and poor prognosis.
Wang L +5 more
europepmc +2 more sources
Factors associated with pneumococcal vaccination uptake in over 50s in Ireland: a cross-sectional study using results from the Irish Longitudinal Study on Ageing (TILDA) [PDF]
Introduction Pneumococcal vaccination is a key global health strategy to reduce the morbidity and mortality associated with pneumococcal disease.Methods This study examined the factors associated with pneumococcal vaccination uptake in community-dwelling
Rose Anne Kenny +5 more
doaj +2 more sources
The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004 [PDF]
Background For winter 2003/2004 in Scotland, it was recommended that all those aged 65 and over be eligible to receive 23-valent polysaccharide pneumococcal vaccine (23vPPV), which has been shown to be effective in reducing the risk of invasive ...
Macfarlane, Tatania V. +8 more
core +5 more sources
The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination [PDF]
More than 90 capsular serotypes of Streptococcus pneumoniae coexist despite competing for nasopharyngeal carriage and a gradient in fitness. The underlying mechanisms for this are poorly understood and make assessment of the likely population impact of ...
Robertson, Charles +5 more
core +5 more sources
Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine [PDF]
Understanding the epidemiology of pneumococcal co-colonization is important for monitoring vaccine effectiveness and the occurrence of horizontal gene transfer between pneumococcal strains.
Sá-Leão, Raquel +40 more
core +2 more sources
Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. [PDF]
OBJECTIVE: To estimate the cost effectiveness of vaccinating people with high risk conditions against invasive pneumococcal disease using the 13 valent pneumococcal conjugate vaccine.
Edmunds, W. John +14 more
core +1 more source

